Skip to content
LATEST
Health

Updated Clinical Guidelines Issued for Menopause Management

New clinical guidelines standardize menopause treatment, recommending hormone therapy for eligible patients and nonhormonal alternatives for others while…

Updated Clinical Guidelines Issued for Menopause Management

New clinical guidelines for menopause management have been issued, establishing standardized protocols for the treatment of vasomotor symptoms and associated sleep disturbances. The guidance strongly recommends menopause hormone therapy for eligible patients, emphasizing individualized risk assessment regarding cardiovascular and oncological history.

For patients unable or unwilling to utilize hormone therapy, the guidelines recommend nonhormonal alternatives, including specific antidepressants and neurokinin receptor antagonists. These pharmacological interventions are intended to address both vasomotor symptoms and depressive symptoms, provided the latter meet diagnostic criteria for major depressive disorder.

Clinical practitioners are advised to initiate hormone therapy before age 60 or within 10 years of menopause onset. The guidelines also highlight systemic inequities in care, noting that demographic factors often influence symptom reporting and treatment access, and advocate for proactive screening to mitigate these disparities.

More stories

Latest news